BPC-157 × valorpeptides.com — lab test, November 2025
Vanguard Laboratory publishes a public verification portal. Any test attributed to this lab can be looked up and confirmed directly with the lab — so this result doesn't rest on our review alone.
This certificate carries no lookup code.
Test results
This is a purity and identity analysis. Sterility, endotoxins, and heavy metals were not screened — a high purity figure says nothing about those.
About this test
Label 10 mg · Lab measured 10.72 mg
107% of label, basis not stated — shown as printed. Reconstituted with 2 mL, a 50-unit draw holds 2.7 mg using the measured mass, against 2.5 mg on the label — 7% more.
One vial from this lot was weighed by the laboratory, not yours. This page reports what the certificate says; it does not recommend a dose.
Independent HPLC purity analysis of BPC-157 from valorpeptides.com, performed by Vanguard Laboratory on November 5, 2025. Reported purity: 99.8%. Net content: 10.72 mg against 10 mg labeled (107% of label). Batch BP1001. Sample source: shop-provided. Certificate of analysis attached.
Certificate of analysis
Other lots of BPC-157 from valorpeptides.com
| Lot | Tested | Lab | Purity | vs label | Status |
|---|---|---|---|---|---|
| ARC-KL80-002 | 4 May 2026 | Accumark Labs | 98.63% | 106% | Lab has no portal |
| ARC-BP10-001 | 30 Apr 2026 | Accumark Labs | 99.25% | 108% | Lab has no portal |
| ARC-WV10-001 | 22 Apr 2026 | Accumark Labs | 98.29% | 119% | Lab has no portal |
| BP2002 | 7 Apr 2026 | Accumark Labs | 99.42% | 103% | Lab has no portal |
| BPT0001 | 6 Mar 2026 | Accumark Labs | 99.62% | 111% | Lab has no portal |
| BP1002 | 13 Feb 2026 | Accumark Labs | 99.051% | 117% | Lab has no portal |
| BP0001 | 1 Oct 2025 | Vanguard Laboratory | 99.8% | 127% | Unverified |
Batches this shop has published a certificate for, newest first. A lot whose printed value cannot identify a batch is not listed.
Have you tested this peptide?
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.
Community discussion